Why does PT-141 cause flushing?

Yes, flushing was measured in the same RECONNECT studies: 1,267 women who had not reached menopause, over 24 weeks. Flushing was listed with nausea and headache, each in 10% or more. The approved product is Vyleesi (bremelanotide). The result on this site does not split that 10% or more into a more exact figure for flushing alone. This FAQ does not invent a tighter rate from that combined list.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of more absences and national fields. Further harvested questions after the first names-and-absences set: more side effects the citations did not count, compounding formulas this catalogue does not hold, national legal-status fields for compounds that only have those four countries, trial windows rather than an onset clock, and named prescription combinations with no interaction table.